Regulation of human COL2A1 gene expression in chondrocytes - Identification of C-Krox-responsive elements and modulation by phenotype alteration

Citation
C. Ghayor et al., Regulation of human COL2A1 gene expression in chondrocytes - Identification of C-Krox-responsive elements and modulation by phenotype alteration, J BIOL CHEM, 275(35), 2000, pp. 27421-27438
Citations number
59
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
275
Issue
35
Year of publication
2000
Pages
27421 - 27438
Database
ISI
SICI code
0021-9258(20000901)275:35<27421:ROHCGE>2.0.ZU;2-L
Abstract
To identify control motifs involved in human type II collagen gene transcri ption in both differentiated and dedifferentiated rabbit articular chondroc ytes, transient transfection experiments were performed, A 715-base pair (b p) region of the first intron (+2127/+2842), including a 153-bp sequence so far uncharacterized (+2689/+2842), was found to mediate enhancer activity. In dedifferentiated chondrocytes, this enhancer activity was shown to be l ess effective than in primary cultures but still present. We then demonstra ted that a zinc finger protein, C-Krox, activates COL2A1 gene transcription in differentiated chondrocytes through the enhancer region, whereas in sub cultured cells, it inhibited the gene activity via a 266-bp promoter. Multi copies of the C-Krox binding site were found to mediate transactivation in both primary cultures and passaged cells, whereas C-Krox overexpression inh ibited transcription in dedifferentiated chondrocytes. Additionally, we sho wed that C-Krox binds to several cis sequences that mediate its transcripti onal effects. During chondrocyte dedifferentiation, the protein levels and binding activity of C-Krox were reduced, whereas those of NF-KB were increa sed. This was not associated with variations of mRNA levels, suggesting tha t post-transcriptional regulatory mechanisms could be involved in C-Krox ex pression. These results suggest that C-Krox plays a major role in type II c ollagen expression and the chondrocyte phenotype modulation.